Evidence map›Paper›PMID 32015540›Full record

ArticleNature neuroscience2020

A myelin-related transcriptomic profile is shared by Pitt-Hopkins syndrome models and human autism spectrum disorder.

BaDoi N Phan, Joseph F Bohlen, Brittany A Davis, Zengyou Ye, Huei-Ying Chen, Brent Mayfield, Srinidhi Rao Sripathy, Stephanie Cerceo Page, Morganne N Campbell, Hannah L Smith and 11 more

Open access · greenAbstract read
In one paragraph

Article in Nature neuroscience, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 97 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
97citing papers in PubMed, 3 pooled it
16.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

97 citing papers in PubMed, 3 syntheses or guidelines pooled it, 149 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Beyond Histamine Blockade: Clemastine Fumarate as a Promoter of Myelin Regeneration, Inflammatory Regulation, and Neuroimmune Modulation in CNS Disorders.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2026
    Review
  5. Article
  6. Article
  7. Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  8. Review
  9. Article
  10. Article
  11. Myelination across the autism spectrum: therapeutic targeting of the oligodendrocyte lineage and myelination defects.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

37 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 4 institutions in 1 country.

BaDoi N Phan *Lieber Institute for Brain Development, Johns Hopkins Medical Campus, Baltimore, MD, USA.ORCID http://orcid.org/0000-0001-6331-5980
Joseph F Bohlen *Lieber Institute for Brain Development, Johns Hopkins Medical Campus, Baltimore, MD, USA.
Brittany A DavisLieber Institute for Brain Development, Johns Hopkins Medical Campus, Baltimore, MD, USA.
Zengyou YeLieber Institute for Brain Development, Johns Hopkins Medical Campus, Baltimore, MD, USA.
Huei-Ying ChenLieber Institute for Brain Development, Johns Hopkins Medical Campus, Baltimore, MD, USA.
Brent MayfieldLieber Institute for Brain Development, Johns Hopkins Medical Campus, Baltimore, MD, USA.
Srinidhi Rao SripathyLieber Institute for Brain Development, Johns Hopkins Medical Campus, Baltimore, MD, USA.
Stephanie Cerceo PageLieber Institute for Brain Development, Johns Hopkins Medical Campus, Baltimore, MD, USA.
Morganne N CampbellLieber Institute for Brain Development, Johns Hopkins Medical Campus, Baltimore, MD, USA.
Hannah L SmithLieber Institute for Brain Development, Johns Hopkins Medical Campus, Baltimore, MD, USA.
Danisha GallopLieber Institute for Brain Development, Johns Hopkins Medical Campus, Baltimore, MD, USA.
Hyojin KimNeuroscience Center, University of North Carolina, Chapel Hill, NC, USA.
Courtney L ThaxtonNeuroscience Center, University of North Carolina, Chapel Hill, NC, USA.ORCID http://orcid.org/0000-0002-6733-369X
Jeremy M SimonNeuroscience Center, University of North Carolina, Chapel Hill, NC, USA.ORCID http://orcid.org/0000-0003-3906-1663
Emily E BurkeLieber Institute for Brain Development, Johns Hopkins Medical Campus, Baltimore, MD, USA.
Joo Heon ShinLieber Institute for Brain Development, Johns Hopkins Medical Campus, Baltimore, MD, USA.
Andrew J KennedyDepartment of Chemistry and Biochemistry, Bates College, Lewiston, ME, USA.
J David SweattDepartment of Pharmacology, Vanderbilt University, Nashville, TN, USA.
Benjamin D PhilpotNeuroscience Center, University of North Carolina, Chapel Hill, NC, USA.ORCID http://orcid.org/0000-0003-2746-9143
Andrew E JaffeLieber Institute for Brain Development, Johns Hopkins Medical Campus, Baltimore, MD, USA. andrew.jaffe@libd.org.ORCID http://orcid.org/0000-0001-6886-1454
Brady J MaherLieber Institute for Brain Development, Johns Hopkins Medical Campus, Baltimore, MD, USA. brady.maher@libd.org.ORCID http://orcid.org/0000-0001-5930-885X
Johns Hopkins University · USUniversity of North Carolina at Chapel Hill · USBates College · USVanderbilt University · US

Funding

UNC MRDD Research CenterP30HD003110 · NICHD · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BELGER, AYSENIL · 1985 to 2012
$28.7M
TRAINING PROGRAM FOR MD/PHD STUDENTST32GM008208 · NIGMS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI STEINMAN, RICHARD A · 1987 to 2021
$15.4M
UNC Neuroscience Center Research Cores: MicroscopyP30NS045892 · NINDS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI ZYLKA, MARK J. · 2003 to 2022
$11.5M
INTERDISCIPLINARY TRAINING PROGRAM IN NEUROSCIENCEST32MH015330 · NIMH · JOHNS HOPKINS UNIVERSITY · PI MARGOLIS, RUSSELL L · 1985 to 2024
$6.2M
Cellular and Molecular Analysis of the Schizophrenia and Autism Spectrum Disorder gene Transcription Factor 4 (TCF4)R01MH110487 · NIMH · LIEBER INSTITUTE, INC. · PI MAHER, BRADY J · 2016 to 2024
$5.2M
Molecular and Behavioral Neurobiology of Transcription Factor TCF4R01MH104158 · NIMH · VANDERBILT UNIVERSITY · PI NISWENDER, COLLEEN M · 2014 to 2018
$1.9M
TCF4 in Pitt-Hopkins syndromeR01NS114086 · NINDS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI PHILPOT, BENJAMIN D · 2019 to 2023
$1.7M
Functional analysis of the Schizophrenia and Autism Spectrum Disorder gene TCF4 iR56MH104593 · NIMH · LIEBER INSTITUTE, INC. · PI MAHER, BRADY J · 2014 to 2015
$915k
NICHD NIH HHS P30 HD003110NIGMS NIH HHS T32 GM008208NIMH NIH HHS R01 MH104158NIMH NIH HHS R01 MH110487NIMH NIH HHS R56 MH104593NIMH NIH HHS T32 MH015330NINDS NIH HHS P30 NS045892NINDS NIH HHS R01 NS114086
6 · The paper itself

Abstract

Autism spectrum disorder (ASD) is genetically heterogeneous with convergent symptomatology, suggesting common dysregulated pathways. In this study, we analyzed brain transcriptional changes in five mouse models of Pitt-Hopkins syndrome (PTHS), a syndromic form of ASD caused by mutations in the TCF4 gene, but not the TCF7L2 gene. Analyses of differentially expressed genes (DEGs) highlighted oligodendrocyte (OL) dysregulation, which we confirmed in two additional mouse models of syndromic ASD (Pten

Indexed as

DNA FingerprintingAgingAnimalsAutism Spectrum DisorderCell CountFaciesGene Expression RegulationHumansHyperventilationIntellectual DisabilityMethyl-CpG-Binding Protein 2MiceMice, KnockoutMyelin SheathOligodendrogliaPrimary Cell CultureMecp2 protein, mouseMethyl-CpG-Binding Protein 2PTEN PhosphohydrolasePten protein, mouseTcf4 protein, mouseTranscription Factor 4

Identifiers

PMID32015540
PMCPMC7065955
OpenAlexW3004223337

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.